The role of PXR and other nuclear receptors in breast cancer provide an extraordinary amount of complexity within transcriptional regulation and extensive crosstalk, which is likely to be confounded within the multiple molecular subtypes of breast cancer. This evidence concerns the gene NR1I2 and breast carcinoma.